STOCKHOLM, 27 October 2020 — Promore Pharma AB (publ) today announced the composition of the Nomination Committee for the Annual General Meeting 2021, which will be held on Thursday 27 May 2021. The Nomination Committee shall, according to decided principles for the appointment of the Nomination Committee, consist of the Chairman of the Board and representatives for the three largest shareholders in the company.
The main task of the Nomination Committee is to submit proposals for Chairman of the Board and other members of the Board, remuneration for Board work, the election and remuneration of auditors. The Nomination Committee shall be composed of the Chairman of the Board and members appointed by the three largest shareholders in the company, or in descending order thereafter should any of the three largest owners decline their right, based on ownership of the Company as per the end of September 2020.
Accordingly, the following committee members have been appointed:
- Göran Pettersson, Chairman of the Board
- David Sundin, representing Midroc New Technology
- Per Lönn, representing PharmaResearch Products
- Arne Andersson
The Nomination Committee’s proposals will be presented in the Notice to the AGM 2021 and on the company web site, www.promorepharma.com. Shareholders desiring to submit comments or proposals to the nomination committee can send them via email to firstname.lastname@example.org.